{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:02:26Z","timestamp":1789794146982,"version":"4.0.1"},"reference-count":34,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.5582\/bst.2026.01202","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:11:11Z","timestamp":1787868671000},"page":"425-437","source":"Crossref","is-referenced-by-count":0,"title":["ATP6L impairs vascular stability in colorectal cancer &lt;i&gt;via&lt;\/i&gt; PDGFB\/PDGFR\u03b2 signaling"],"prefix":"10.5582","volume":"20","author":[{"given":"Xiangdong","family":"Tian","sequence":"first","affiliation":[{"name":"Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin&apos;s Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Chen","sequence":"first","affiliation":[{"name":"Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin&apos;s Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin, China."},{"name":"Department of Pathology, Cangzhou People&apos;s Hospital, Cangzhou, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Duo","sequence":"first","affiliation":[{"name":"Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin&apos;s Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin&apos;s Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Qi","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin&apos;s Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Guelfi S, Hodivala-Dilke K, Bergers G. Targeting the tumour vasculature: from vessel destruction to promotion. Nat Rev Cancer. 2024; 24:655-675.","DOI":"10.1038\/s41568-024-00736-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Martin JD, Seano G, Jain RK. Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges. Annu Rev Physiol. 2019; 81:505-534.","DOI":"10.1146\/annurev-physiol-020518-114700"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Magnussen AL, Mills IG. Vascular normalisation as the stepping stone into tumour microenvironment transformation. Br J Cancer. 2021; 125:324-336.","DOI":"10.1038\/s41416-021-01330-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005; 307:58-62.","DOI":"10.1126\/science.1104819"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jordan AM, Drake RJG, Hodivala-Dilke KM. Angiocrine and pericrine signaling: how endothelial cells and pericytes drive cancer progression and therapy resistance. Physiol Rev. 2026; 106:87-119.","DOI":"10.1152\/physrev.00046.2024"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tian L, Goldstein A, Wang H, <i>et al<\/i>. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature. 2017; 544:250-254.","DOI":"10.1038\/nature21724"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zhu J, Yang W, Ma J, He H, Liu Z, Zhu X, He X, He J, Chen Z, Jin X, Wang X, He K, Wei W, Hu J. Pericyte signaling <i>via<\/i> soluble guanylate cyclase shapes the vascular niche and microenvironment of tumors. EMBO J. 2024; 43:1519-1544.","DOI":"10.1038\/s44318-024-00078-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gomez D, Owens GK. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res. 2012; 95:156-164.","DOI":"10.1093\/cvr\/cvs115"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pan X, Li X, Dong L, <i>et al<\/i>. Tumour vasculature at single-cell resolution. Nature. 2024; 632:429-436.","DOI":"10.1038\/s41586-024-07698-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Swietach P, Boedtkjer E, Pedersen SF. How protons pave the way to aggressive cancers. Nat Rev Cancer. 2023; 23:825-841.","DOI":"10.1038\/s41568-023-00628-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Corbet C, Feron O. Tumour acidosis: from the passenger to the driver&apos;s seat. Nat Rev Cancer. 2017; 17:577-593.","DOI":"10.1038\/nrc.2017.77"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol. 2007; 8:917-929.","DOI":"10.1038\/nrm2272"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cotter K, Capecci J, Sennoune S, Huss M, Maier M, Martinez-Zaguilan R, Forgac M. Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells. J Biol Chem. 2015; 290:3680-3692.","DOI":"10.1074\/jbc.M114.611210"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zeng S, Chen J, Ren Y, <i>et al<\/i>. Multiscale imaging on proton pump-driven acidity for assessing tumor progression and metastasis. Nat Commun. 2026; 17:1785.","DOI":"10.1038\/s41467-026-68491-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. You H, Jin J, Shu H, Yu B, Milito AD, Lozupone F, Deng Y, Tang N, Yao G, Fais S, Gu J, Qin W. Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells. Cancer Lett. 2009; 280:110-119.","DOI":"10.1016\/j.canlet.2009.02.023"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Stransky L, Cotter K, Forgac M. The Function of V-ATPases in Cancer. Physiol Rev. 2016; 96:1071-1091.","DOI":"10.1152\/physrev.00035.2015"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wang J, Chen D, Song W, Liu Z, Ma W, Li X, Zhang C, Wang X, Wang Y, Yang Y, Cao W, Qi L. ATP6L promotes metastasis of colorectal cancer by inducing epithelial-mesenchymal transition. Cancer Sci. 2020; 111:477-488.","DOI":"10.1111\/cas.14283"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tian X, Xia Y, Gong W, Zhu K, Yang Y, Han Z, Liu Y, Li J, Li X, He Y, Gao M, Chen L, Guo H, Zhao Q. PLK4 as a Key Regulator of Neuroblastoma Differentiation and a Promising Therapeutic Target. Int J Biol Sci. 2025; 21:4979-4996.","DOI":"10.7150\/ijbs.111449"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Qin Y, Zhao W. The Modeling Analysis and Effect of CHI3L1 and CD31-Marked Microvessel Density in the Occurrence and Development of Cervical Squamous Cell Carcinoma. Comput Math Methods Med. 2022; 2022:3516335.","DOI":"10.1155\/2022\/3516335"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Guo Z, Cao Y. Mechanisms of Pericyte-Mediated Cancer Metastasis. Adv Sci (Weinh). 2026; 13:e00031.","DOI":"10.1002\/advs.202600031"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lee SJ, Kim S, Jo DH, Cho CS, Kim SR, Kang D, Chae J, Yoo DK, Ha S, Chung J, Kim JH. Specific ablation of PDGFR\u03b2-overexpressing pericytes with antibody-drug conjugate potently inhibits pathologic ocular neovascularization in mouse models. Commun Med (Lond). 2021; 1:58.","DOI":"10.1038\/s43856-021-00059-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lee HW, Xu Y, Zhu X, Jang C, Choi W, Bae H, Wang W, He L, Jin SW, Arany Z, Simons M. Endothelium-derived lactate is required for pericyte function and blood-brain barrier maintenance. EMBO J. 2022; 41:e109890.","DOI":"10.15252\/embj.2021109890"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zou MZ, Liu WL, Chen HS, Bai XF, Gao F, Ye JJ, Cheng H, Zhang XZ. Advances in nanomaterials for treatment of hypoxic tumor. Natl Sci Rev. 2021; 8:nwaa160.","DOI":"10.1093\/nsr\/nwaa160"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wang R, Wang J, Hassan A, Lee CH, Xie XS, Li X. Molecular basis of V-ATPase inhibition by bafilomycin A1. Nat Commun. 2021; 12:1782.","DOI":"10.1038\/s41467-021-22111-5"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Liu Z, Sun B, Qi L, Li Y, Zhao X, Zhang D, Zhang Y. Dickkopf-1 expression is down-regulated during the colorectal adenoma-carcinoma sequence and correlates with reduced microvessel density and VEGF expression. Histopathology. 2015; 67:158-166.","DOI":"10.1111\/his.12474"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Staton CA, Chetwood AS, Cameron IC, Cross SS, Brown NJ, Reed MW. The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut. 2007; 56:1426-1432.","DOI":"10.1136\/gut.2007.125286"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Suvac A, Ashton J, Bristow RG. Tumour hypoxia in driving genomic instability and tumour evolution. Nat Rev Cancer. 2025; 25:167-188.","DOI":"10.1038\/s41568-024-00781-9"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest. 2003; 112:1142-1151.","DOI":"10.1172\/JCI200318549"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Lindahl P, Johansson BR, Lev\u00e9en P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997; 277:242-245.","DOI":"10.1126\/science.277.5323.242"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sun R, Kong X, Qiu X, Huang C, Wong PP. The Emerging Roles of Pericytes in Modulating Tumor Microenvironment. Front Cell Dev Biol. 2021; 9:676342.","DOI":"10.3389\/fcell.2021.676342"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kasurinen JH, Hagstr\u00f6m J, Kaprio T, Jalkanen S, Salmi M, B\u00f6ckelman C, Haglund C. Prognostic Values of Tissue and Serum Angiogenic Growth Factors Depend on the Phenotypic Subtypes of Colorectal Cancer. Cancers (Basel). 2023; 15.","DOI":"10.3390\/cancers15153871"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Zhang Y, Cedervall J, Hamidi A, <i>et al<\/i>. Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis. Cancer Res. 2020; 80:3345-3358.","DOI":"10.1158\/0008-5472.CAN-19-3533"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Huinen ZR, Huijbers EJM, van Beijnum JR, Nowak-Sliwinska P, Griffioen AW. Anti-angiogenic agents\u2014overcoming tumour endothelial cell anergy and improving immunotherapy outcomes. Nat Rev Clin Oncol. 2021; 18:527-540.","DOI":"10.1038\/s41571-021-00496-y"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Hosaka K, Yang Y, Seki T, <i>et al<\/i>. Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis. Nat Commun. 2013; 4:2129.","DOI":"10.1038\/ncomms3129"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/20\/4\/20_2026.01202\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:29:17Z","timestamp":1789792157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/20\/4\/20_2026.01202\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2026.01202","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"2026.01202"}}